(-0.03%) 5 467.61 points
(0.13%) 39 165 points
(0.18%) 17 749 points
(0.00%) $80.83
(-5.04%) $2.62
(-0.85%) $2 310.90
(-0.24%) $28.80
(3.13%) $1 017.30
(0.34%) $0.936
(0.76%) $10.68
(0.52%) $0.792
(-0.27%) $87.25
2.70% $ 1.900
Live Chart Being Loaded With Signals
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States...
Stats | |
---|---|
Volumen de hoy | 267 893 |
Volumen promedio | 480 976 |
Capitalización de mercado | 131.12M |
EPS | $-0.230 ( Q1 | 2024-05-02 ) |
Próxima fecha de ganancias | ( $-0.220 ) 2024-08-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-2.16 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00600 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-30 | Coughlin Timothy | Buy | 50 000 | Common Stock |
2024-05-31 | Broadfoot Jill Marie | Buy | 5 000 | Common Stock |
2024-05-31 | Shukla Sanjay | Buy | 20 000 | Common Stock |
2024-05-22 | Clarke John K | Buy | 24 000 | Stock Option (right to buy) |
2024-05-22 | Gross Jane A | Buy | 24 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
94.01 |
Last 99 transactions |
Buy: 4 165 378 | Sell: 335 127 |
Volumen Correlación
aTyr Pharma Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
RDWR | 0.803 |
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
aTyr Pharma Inc Correlación - Moneda/Commodity
aTyr Pharma Inc Finanzas
Annual | 2023 |
Ingresos: | $353 000 |
Beneficio Bruto: | $-2.39M (-676.49 %) |
EPS: | $-0.940 |
FY | 2023 |
Ingresos: | $353 000 |
Beneficio Bruto: | $-2.39M (-676.49 %) |
EPS: | $-0.940 |
FY | 2022 |
Ingresos: | $10.39M |
Beneficio Bruto: | $8.69M (83.68 %) |
EPS: | $-1.560 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.770 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
aTyr Pharma Inc
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. It is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. The company was incorporated in 2005 and is headquartered in San Diego, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico